Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FNBP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MIR612 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
FLI1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FYTTD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CENPJ - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DPAGT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TARS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPATS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZADH2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WWC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNX4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKRD49 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CSNK1A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLCL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEP57 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDS5B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AMZ2P1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
URI1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on